A detailed history of Allred Capital Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Allred Capital Management, LLC holds 7,915 shares of ABBV stock, worth $1.54 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares
7,915
Previous 7,692 2.9%
Holding current value
$1.54 Million
Previous $1.4 Million 3.07%
% of portfolio
0.53%
Previous 0.55%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$154.79 - $180.76 $34,518 - $40,309
223 Added 2.9%
7,915 $1.36 Million
Q1 2024

Apr 16, 2024

SELL
$159.82 - $182.1 $28,288 - $32,231
-177 Reduced 2.25%
7,692 $1.4 Million
Q4 2023

Jan 12, 2024

BUY
$137.6 - $154.97 $42,793 - $48,195
311 Added 4.11%
7,869 $1.22 Million
Q3 2023

Nov 08, 2023

SELL
$133.59 - $154.65 $31,260 - $36,188
-234 Reduced 3.0%
7,558 $1.13 Million
Q2 2023

Jul 20, 2023

SELL
$132.51 - $164.9 $63,604 - $79,152
-480 Reduced 5.8%
7,792 $1.05 Million
Q1 2023

May 09, 2023

BUY
$144.61 - $166.54 $26,174 - $30,143
181 Added 2.24%
8,272 $1.32 Million
Q4 2022

Feb 14, 2023

BUY
$138.31 - $165.87 $11,341 - $13,601
82 Added 1.02%
8,091 $1.31 Million
Q3 2022

Oct 27, 2022

BUY
$134.21 - $153.93 $85,089 - $97,591
634 Added 8.6%
8,009 $1.07 Million
Q2 2022

Aug 09, 2022

SELL
$137.62 - $174.96 $57,662 - $73,308
-419 Reduced 5.38%
7,375 $1.13 Million
Q1 2022

May 05, 2022

SELL
$131.98 - $163.75 $64,538 - $80,073
-489 Reduced 5.9%
7,794 $1.26 Million
Q4 2021

Jan 25, 2022

SELL
$107.43 - $135.93 $66,069 - $83,596
-615 Reduced 6.91%
8,283 $1.12 Million
Q3 2021

Oct 12, 2021

SELL
$106.4 - $120.78 $66,819 - $75,849
-628 Reduced 6.59%
8,898 $960,000
Q2 2021

Aug 05, 2021

SELL
$105.21 - $117.21 $44,293 - $49,345
-421 Reduced 4.23%
9,526 $1.07 Million
Q1 2021

May 06, 2021

SELL
$102.3 - $112.62 $12,378 - $13,627
-121 Reduced 1.2%
9,947 $1.08 Million
Q4 2020

Jan 21, 2021

BUY
$80.49 - $108.67 $38,635 - $52,161
480 Added 5.01%
10,068 $1.08 Million
Q3 2020

Oct 14, 2020

BUY
$85.91 - $100.83 $3,865 - $4,537
45 Added 0.47%
9,588 $839,000
Q2 2020

Aug 13, 2020

BUY
$73.37 - $98.18 $7,703 - $10,308
105 Added 1.11%
9,543 $936,000
Q1 2020

Apr 17, 2020

BUY
$64.5 - $97.79 $16,060 - $24,349
249 Added 2.71%
9,438 $719 Million
Q4 2019

Jan 13, 2020

SELL
$72.13 - $90.25 $126,876 - $158,749
-1,759 Reduced 16.07%
9,189 $813,000
Q3 2019

Oct 07, 2019

SELL
$62.98 - $75.72 $7,620 - $9,162
-121 Reduced 1.09%
10,948 $801,000
Q2 2019

Jul 18, 2019

SELL
$65.7 - $83.98 $31,733 - $40,562
-483 Reduced 4.18%
11,069 $821,000
Q1 2019

Apr 16, 2019

BUY
$77.14 - $90.79 $7,636 - $8,988
99 Added 0.86%
11,552 $958,000
Q4 2018

Jan 31, 2019

BUY
$77.85 - $96.01 $891,616 - $1.1 Million
11,453 New
11,453 $1.06 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $344B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Allred Capital Management, LLC Portfolio

Follow Allred Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allred Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allred Capital Management, LLC with notifications on news.